|
|
Volumn 372, Issue 8, 2014, Pages 783-
|
|
Genetic basis for clinical response to CTLA-4 blockade
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER NEOEPITOPE;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY;
EPITOPE;
HEPATITIS ANTIBODY;
HEPATITIS D ANTIBODY;
HLA ANTIGEN;
MAJOR HISTOCOMPATIBILITY ANTIGEN;
T LYMPHOCYTE RECEPTOR;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
DRUG CROSS REACTIVITY;
DRUG RESPONSE;
GENETIC ASSOCIATION;
HLA GENE;
HUMAN;
LETTER;
MELANOMA;
MOLECULAR EVOLUTION;
OUTCOME ASSESSMENT;
PHARMACOGENETICS;
SEROLOGY;
ANTAGONISTS AND INHIBITORS;
FEMALE;
GENETICS;
MALE;
SKIN TUMOR;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CTLA-4 ANTIGEN;
FEMALE;
HUMANS;
MALE;
MELANOMA;
SKIN NEOPLASMS;
|
|
EID: 84923067538
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1415938 Document Type: Letter |
|
Times cited : (20)
|
|
References (1)
|
